Video

Juergen Klenk on the Cancer XPRIZE

Author(s):

Juergen Klenk of Deloitte Consulting discusses their partnership with the XPRIZE foundation to build a cancer XPRIZE competition.

Juergen Klenk, Deloitte Consulting, discusses the partnership with the XPRIZE Foundation and their cancer XPRIZE competition.

When planning a cancer XPRIZE, there were a lot of aspects to choose from. Eventually, the group landed upon a concept: What if we could make cancer detection as easy as a pregnancy test? From there, the Cancer XPRIZE was born.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Related Content